Prime Medicine
| Company type | Public |
|---|---|
| ISIN | US74168J1016 |
| Industry | Biotechnology |
| Founded | 2019 |
| Founders |
|
| Headquarters | Cambridge, Massachusetts, U.S. |
Key people |
|
| Website | primemedicine |
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.